scholarly journals Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial

2014 ◽  
Vol 135 (11) ◽  
pp. 2612-2622 ◽  
Author(s):  
Feng-Cai Zhu ◽  
Wen Chen ◽  
Yue-Mei Hu ◽  
Ying Hong ◽  
Juan Li ◽  
...  
2010 ◽  
Vol 46 (5) ◽  
pp. 414-421 ◽  
Author(s):  
Doris M. Rivera Medina ◽  
Alejandra Valencia ◽  
Alet de Velasquez ◽  
Li-Min Huang ◽  
Roman Prymula ◽  
...  

2022 ◽  
Author(s):  
Na Wang ◽  
Jenny Gamble ◽  
Qiuxiang Zhang ◽  
Elizabeth Elder ◽  
Jyai Allen ◽  
...  

Abstract Background:Undergoing an abortion is stressful. This protocol aims to assess the feasibility, acceptability, and primary effects of a complex intervention to promote positive coping behaviors and alleviating depression symptoms among Chinese women undergo abortion.Methods:A two-arm randomized controlled trial design will be used. Participants will be recruited at their first appointment with the abortion clinic, those who consent to participate will be randomly allocated to receive either the START intervention (in addition to standard abortion care) or standard care only. All participants will receive survey follow-up until six weeks post-abortion. Ethical has been granted by local and university ethics committees. This research was supported by an Australian Government Research Training Program (RTP) Scholarship Discussion:Results will assist refinement and further evaluations of the START intervention, contribute to improved abortion care practices in China, and enrich the literature evidence on improving women’s psychological well-being following abortion in ChinaTrial registration: Registered at the Chinese Clinical Trials.gov: ChiCTR2100046101. Date of registration: May 4, 2021


Sign in / Sign up

Export Citation Format

Share Document